Order Article Reprints

Shapoval O, Větvička D, Patsula V, Engstová H, Kočková O, Konefał M, Kabešová M, Horák D. Temoporfin-Conjugated Upconversion Nanoparticles for NIR-Induced Photodynamic Therapy: Studies with Pancreatic Adenocarcinoma Cells In Vitro and In Vivo. Pharmaceutics. 2023; 15(12):2694. https://doi.org/10.3390/pharmaceutics15122694

Shapoval, Oleksandr, David Větvička, Vitalii Patsula, Hana Engstová, Olga Kočková, Magdalena Konefał, Martina Kabešová, and Daniel Horák. 2023. "Temoporfin-Conjugated Upconversion Nanoparticles for NIR-Induced Photodynamic Therapy: Studies with Pancreatic Adenocarcinoma Cells In Vitro and In Vivo" Pharmaceutics 15, no. 12: 2694. https://doi.org/10.3390/pharmaceutics15122694

Shapoval, O., Větvička, D., Patsula, V., Engstová, H., Kočková, O., Konefał, M., Kabešová, M., & Horák, D. (2023). Temoporfin-Conjugated Upconversion Nanoparticles for NIR-Induced Photodynamic Therapy: Studies with Pancreatic Adenocarcinoma Cells In Vitro and In Vivo. Pharmaceutics, 15(12), 2694. https://doi.org/10.3390/pharmaceutics15122694